-
FGFR2-IN-1
2025-08-01
-
Recombinant Human MIP-4CCL18
2025-07-31
-
Anti-MUC16 Antibody (Sofituzumab vedotin)
2025-07-31
-
Cy5 maleimide (non-sulfonated)
2025-07-30
-
C29
2025-07-30
-
3-hydroxy Anthranilic Acid
2025-07-29
-
2',5'-Dihydroxyacetophenone
2025-07-29
-
Nepicastat (SYN-117) HCl
2025-07-28
-
Clindamycin palmitate HCl
2025-07-28
-
Pyrantel Pamoate
2025-07-25
-
Mulberroside C
2025-07-24
-
JH-VIII-157-02
2025-07-23
-
Anti-NQO2 Rabbit Monoclonal Antibody
2025-07-22
-
Etretinate
2025-07-22
-
Chlorpyrifos
2025-07-21